Innovative Pain Measurement PainQx offers a cutting-edge solution for objective pain assessment through EEG analysis, which is highly valuable for clinical research institutions and pharmaceutical companies looking to develop or validate new analgesics.

Expanding Clinical Use The system's proven efficacy in clinical settings and its ability to measure unarticulated pain positions it as a crucial tool for hospitals, pain clinics, and research organizations aiming to improve diagnostic accuracy and treatment outcomes.

Strong IP Position With a proprietary algorithm and proven results, PainQx’s intellectual property allows for differentiation in the pain assessment market, making it attractive to partner with medical device manufacturers or healthcare providers seeking innovative diagnostic tools.

Funding & Growth Potential Despite a modest funding level of 1.5 million dollars, PainQx’s growth potential is notable given its innovative approach and market niche, making it a compelling opportunity for investors or strategic partners interested in healthcare technology.

Limited Competition PainQx operates in a specialized segment with few direct competitors, providing opportunities to establish early partnerships with research institutions, hospitals, and pharmaceutical companies exploring objective pain measurement solutions.